Mouse BCMA / TNFRSF17 Protein, His Tag
分子別名(Synonym)
TNFRSF17,CD269,BCM,BCMA
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Mouse BCMA, His Tag (BCA-M52H3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Thr 49 (Accession # O88472-1).
蛋白結(jié)構(gòu)(Molecular Characterization)
![1.jpg 1.jpg](/SupplyImg1/2025-01-20/6387296796033474886194566.jpg)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 7.5 kDa. The protein migrates as 13 kDa and 14 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![2.jpg 2.jpg](/SupplyImg1/2025-01-20/6387296796783728617903274.jpg)
![3.jpg 3.jpg](/SupplyImg1/2025-01-20/6387296797137297895057334.jpg)
背景(Background)
腫瘤壞死因子受體超家族成員17(TNFRSF17)也稱為B細(xì)胞成熟蛋白(BCMA)、CD抗原CD269,是TNF受體超家族的成員。TNFRSF17包含一個(gè)TNFR-Cys重復(fù)序列。TNFRSF17在成熟的B細(xì)胞中表達(dá),但在T細(xì)胞或單核細(xì)胞中不表達(dá)。TNFRSF17是TNFSF13B/BLyS/BAFF和TNFSF13/APIL的受體。TNFRSF117促進(jìn)B細(xì)胞存活,并在調(diào)節(jié)體液免疫中發(fā)揮作用。TNFRSF17可以激活NF-kappa-B和JNK。
關(guān)鍵字: BCMA;BCMA蛋白;BCMA重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。